[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342110-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342110-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unravelling-mutational-signatures-with-plasma-circulating-tumour-dna-mismatchfinder-liquid-biopsy-method","Unravelling mutational signatures with plasma circulating tumour DNA - MisMatchFinder liquid biopsy method","","Circulating tumour DNA (ctDNA) enables non-invasive profiling of mutational signatures that reflect cancer mutational processes. The study introduces MisMatchFinder, a liquid biopsy approach using low-coverage whole-genome sequencing of ctDNA. By analysing 375 plasma samples across nine cancers, it accurately infers single- and doublet-base substitutions, as well as insertions and deletions. The read-based inference pipeline improves detection of clinically relevant mutational signatures without requiring invasive tumour tissue.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unravelling-mutational-signatures-with-plasma-circulating-tumour-dna-mismatchfinder-liquid-biopsy-method/342110/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unravelling-mutational-signatures-with-plasma-circulating-tumour-dna-mismatchfinder-liquid-biopsy-method/342110.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does MisMatchFinder address in mutational signature analysis?","Question",{"text":63,"@type":64},"It addresses clinical implementation challenges, where accurate signature calling typically requires costly deep sequencing of both tumour and germline samples and sometimes lacks available tumour tissue. MisMatchFinder focuses on ctDNA to support signature detection with low-coverage sequencing.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MisMatchFinder detect mutational signatures from ctDNA?",{"text":68,"@type":64},"MisMatchFinder uses a read-based somatic variant inference step before signature deconvolution. It identifies high-confidence mismatches within reads, applies germline filtering (including gnomAD-based filtering) and ctDNA-centric fragmentomics filtering, then fits or extracts mutational signatures.",{"name":70,"@type":61,"acceptedAnswer":71},"What sequencing data and mutation types does the method support?",{"text":72,"@type":64},"The tool is tailored for low-coverage whole-genome sequencing (under 10×) of ctDNA. It supports single-base and doublet-base substitutions, as well as insertions and deletions (indels) for assigning weights to signatures in COSMIC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342110,1790131791,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Article [https://doi.org/10.1038/s41467-024-54193-2](https://doi.org/10.1038/s41467-024-54193-2)  \nUnravelling mutational signatures with plasma circulating tumour DNA  \nReceived: 25 January 2024  \n\n| Accepted: 4 November 2024 |\n| --- |\n| |\n| Check for updates |\n\nSebastian Hollizeck 1,2,5, Ning Wang1,2,5, Stephen Q. Wong1,2,  \nCassandra Litchﬁeld1, Jerick Guinto1, Sarah Ftouni1, Richard Rebello 3, Sehrish Kanwal 3, Ruining Dong 3, Sean Grimmond 3, Shahneen Sandhu1,2, Linda Mileshkin 1,2, Richard W. Tothill 2,3,4, Dineika Chandrananda 1,2,6  & Sarah-Jane Dawson 1,2,3,6   \nThe use of circulating tumour DNA (ctDNA) to proﬁle mutational signatures represents a non-invasive opportunity for understanding cancer mutational processes. Here we present MisMatchFinder, a liquid biopsy approach for mutational signature detection using low-coverage whole-genome sequencing of ctDNA. Through analysis of 375 plasma samples across 9 cancers, we demonstrate that MisMatchFinder accurately infers single-base and doubletbase substitutions, as well as insertions and deletions to enhance the detection of ctDNA and clinically relevant mutational signatures.  \nMutational signatures are distinct patterns of DNA mutations imprinted on tumour genomes by diverse processes during cancer development1–3. Certain intrinsic pathway errors in DNA replication or repair such as mismatch repair deﬁciency (dMMR) and homologous recombination deﬁciency (HRD) lead to mutational signatures that if correctly detected, can predict sensitivity to speciﬁc therapeutics including immunotherapy in patients with dMMR4,5 and PARP inhibitors in patients with HRD6,7. Thus, mutational signature analysis is invaluable to understanding tumour biology and personalising treatments for better clinical outcomes. However, implementation of mutational signature analysis in the clinic is currently challenging due to the need for costly deep sequencing of both tumour and germline samples for accurate somatic variant calling. Moreover, tumour tissue is not always available. Alternative methods are therefore needed to help overcome these challenges.  \nIn this work, we developed a method called MisMatchFinder which shifts away from a traditional variant-focused approach and instead utilises read-based somatic variant inference prior to mutational signature deconvolution (Fig. 1a). The tool is suitable for lowcoverage whole-genome sequencing (LCWGS) data (\u003C10×) and is tailored for circulating tumour DNA (ctDNA), thus offering a means to characterise mutational signatures without the need for invasive biopsies.  \nResults  \nDescription and performance of MisMatchFinder in simulated and clinical sequencing data  \nThe MisMatchFinder algorithm identiﬁes mismatches within reads compared to the reference genome and ﬁlters background noise unrelated to somatic mutations through (i) the use of high thresholds for mapping and base quality, (ii) strict consensus between overlapping read-pairs,(iii) gnomAD-based germline variant ﬁltering8, and (iv) a ctDNA-centric fragmentomicsﬁlter9 (Fig. 1a) . Aread depth ﬁlter is optional and allows for scaling beyond low sequencing coverage, providing additional ﬂexibility. Once high-conﬁdence mismatches are selected, these can be used to extract novel signatures or ﬁt predeﬁned ones2. MisMatchFinder is equipped to analyse single-base, and doublet-base substitutions, as well as insertions and deletions (indels). In this study, we utilised all three types to assign weights to the mutational signatures in the Catalogue Of Somatic Mutations In Cancer (COSMIC) database (version 3.2)1 using non-negative matrix factorization with quadratic programing10. To identify signatures that were over-represented in ctDNA rather than normal cell-free DNA (cfDNA), we derived detection thresholds using signature weights from a panel of healthy cfDNA controls (details in “Methods”).  \nTo optimise the performance of MisMatchFinder, we systematically tested each ﬁltering step using both in ","cbCaii3CxZAvRW9u","https://ap.wps.com/l/cbCaii3CxZAvRW9u","pdf",1502088,"English","# Results\n## Description and performance of MisMatchFinder in simulated and clinical sequencing data","[{\"question\":\"What problem does MisMatchFinder address in mutational signature analysis?\",\"answer\":\"It addresses clinical implementation challenges, where accurate signature calling typically requires costly deep sequencing of both tumour and germline samples and sometimes lacks available tumour tissue. MisMatchFinder focuses on ctDNA to support signature detection with low-coverage sequencing.\"},{\"question\":\"How does MisMatchFinder detect mutational signatures from ctDNA?\",\"answer\":\"MisMatchFinder uses a read-based somatic variant inference step before signature deconvolution. It identifies high-confidence mismatches within reads, applies germline filtering (including gnomAD-based filtering) and ctDNA-centric fragmentomics filtering, then fits or extracts mutational signatures.\"},{\"question\":\"What sequencing data and mutation types does the method support?\",\"answer\":\"The tool is tailored for low-coverage whole-genome sequencing (under 10×) of ctDNA. It supports single-base and doublet-base substitutions, as well as insertions and deletions (indels) for assigning weights to signatures in COSMIC.\"}]","Unravelling mutational signatures with plasma circulating tumour DNA - MisMatchFinder liquid biopsy method | PDF",1790045284,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0875463ece0a8fe6728c4ced9003326.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56509afc0ba6f2c012cafe6134595e59.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5807021b22c2fc057ef29654cbf01231.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f8fbbc80c71d3195c7a97463237206f.webp",980,1301]